Jonathan McNeill, Chief Business Officer at Dyne Therapeutics, Inc. (DYN), sold 39,822 shares at $24.52 ($977K) on 2024-01-26, disclosed to the SEC on 2024-01-26.
Scheduled sale ($977k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.52 | 19,822 | $486K | 49.8% |
| 2 | $24.52 | 19,822 | $486K | 49.8% |
| 3 | $25.14 | 178 | $4K | 0.5% |
| Total | $24.52 avg | 39,822 | $977K | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $122K | — | Filing → |
| DYN | SELL | 2024-06-11 | $114K | — | Filing → |
| DYN | SELL | 2024-05-17 | $143K | — | Filing → |